Skip to main content
Clinical Trials/NCT05076383
NCT05076383
Unknown
N/A

The Effect of Motor Re-Learning Program on Balance, Mobility and Performance of Activities of Daily Living Among Post-Stroke Patients: A Randomized Controlled Trial

Parc de Salut Mar1 site in 1 country66 target enrollmentOctober 1, 2021
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Parc de Salut Mar
Enrollment
66
Locations
1
Primary Endpoint
Instrumental analysis of gait
Last Updated
3 years ago

Overview

Brief Summary

The primary objective of this study is to assess - through a randomized controlled trial - the effectiveness and long-term improvement of motor relearning program on balance, mobility and performance of activities of daily living among post-stroke patients. In this two-armed randomized controlled clinical trial, a total of 66 sub-acute stroke patients who meet the trial criteria will be recruited. The patients will randomly receive task-specific training based on a motor relearning program (MRP) or a conventional physical therapy program (CPT). Twenty-four rehabilitation sessions will be conducted for eight weeks. Both interventions will be followed by analysis of patients' balance, gait and performance of activates of daily living at two time period; post-intervention and follow-up after 3-months, using clinical outcome measures and instrumental analysis of balance and gait.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
January 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Parc de Salut Mar
Responsible Party
Principal Investigator
Principal Investigator

Amer Ghrouz

Principal Investigator

Parc de Salut Mar

Eligibility Criteria

Inclusion Criteria

  • First-ever subacute (1-6 months) stroke patients;
  • Able to give informed consent;
  • Patients with hemiparesis: muscle power of 2-4 on Medical Research Council-MRC Muscle Scale in the affected upper and lower limbs;
  • Able to stand independently for at least one minute;
  • Can ambulate 25 feet/10 meter (with or without assistive device).

Exclusion Criteria

  • Post-stroke patients with major cognitive deficits (Montreal Cognitive Assessment- MoCA score ≥ 20) and/or communication impairments that don't allow patients to follow directions (i.e., deafness, aphasia, etc.);
  • Patients who are receiving other related therapy through the study, which may affect efficacy of this study;
  • Any medical contraindications to start rehabilitation;
  • History of disability related to neurological deficits other than stroke.

Outcomes

Primary Outcomes

Instrumental analysis of gait

Time Frame: NedAMH/IBV® system will be used to assess the changes from baseline gait parameters at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

The gait will be assessed using the NedAMH/IBV® system, a software application for the biomechanical gait assessment, based on the use of a Dinascan/IBV P600 dynamometric platform.

Timed Up and Go Test (TUG)

Time Frame: The TUG will be used to evaluate the changes from baseline functional mobility at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

10-meter Walk Test (10mWT)

Time Frame: The 10mWT will be used to assess the changes from the baseline walking speed (meters per second) at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

Barthel Index (BI)

Time Frame: The BI will be used to measure the changes from baseline functional independency at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

Berg Balance Scale (BBS)

Time Frame: The BBS will be used to assess the changes from the baseline balance at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

Instrumental analysis of balance

Time Frame: NedSVE/IBV® system will be used to assess the changes from baseline balance and postural control at 8 weeks (post-intervention) as well as at 3-months after intervention (3-months follow-up).

The balance and postural control will be assessed using the computerized posturography - NedSVE/IBV® platform.

Study Sites (1)

Loading locations...

Similar Trials